GlassScriptPhysician profile
Matthew J Kraeutler
NPI 1568982007
$31,198.39
in general payments reported to CMS, 2019-2025
11 companies · $4,509 in 2025
The $4,509 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,848 · 2023: $2,999 · 2024: $22K · 2025: $4,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $11K · Food and Beverage: $3,797 · Education: $1,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,350.00 |
| Travel and Lodging | $10,537.01 |
| Food and Beverage | $3,796.54 |
| Education | $1,666.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22,074.13 | 2022-2025 | Q-Fix, Microraptor, Healicoil |
| Vericel Corporation | $2,693.41 | 2023-2025 | Maci |
| Rattan and Associates | $2,022.54 | 2024-2025 | |
| Stryker Corporation | $1,978.68 | 2023-2025 | Blueprint Patient Specific Instrumentation, Iconix, Salvation |
| Arthrex, INC. | $1,428.01 | 2023-2025 | |
| Moximed, INC | $487.36 | 2025 | Misha Knee System, Small, Left |
| Linvatec Corporation | $329.51 | 2025 | Biobrace 23mm, Livatec Knee Preservation System |
| Bioventus LLC | $86.31 | 2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Organogenesis INC. | $50.72 | 2025 | Puraply Wound Matrix |
| Medinc of Texas | $30.64 | 2023 | |
| Ossur Americas, INC. | $17.08 | 2024 | I-Digits Quantum |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kraeutler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.